APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Therapeutic Radioisotopes

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Therapeutic Radioisotopes Market Outlook and Growth Opportunities 2026

Report ID 174040810420 December 2025198 pages

Choose your research edition.

Industry ResearchTherapeutic Radioisotopes Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Therapeutic Radioisotopes Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Therapeutic Radioisotopes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Therapeutic Radioisotopes Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Therapeutic Radioisotopes Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Therapeutic Radioisotopes market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Therapeutic Radioisotopes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Therapeutic Radioisotopes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Therapeutic Radioisotopes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Therapeutic Radioisotopes market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Therapeutic Radioisotopes market include Novartis, Bayer, Q BioMed, Mundipharma, Lantheus, Jubilant Radiopharma, International Isotopes, Dongcheng and Curium Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Therapeutic Radioisotopes market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Therapeutic Radioisotopes and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Therapeutic Radioisotopes sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Therapeutic Radioisotopes market size, projected growth trends, production technologies, key applications, and end-use industries.

Therapeutic Radioisotopes Segment by Company

Novartis

Bayer

Q BioMed

Mundipharma

Lantheus

Jubilant Radiopharma

International Isotopes

Dongcheng

Curium Pharmaceuticals

China Isotope & Radiation

Aurobindo Pharma

Therapeutic Radioisotopes Segment by Type

Lutetium-177

Radium-223

Iodine-131

Other

Therapeutic Radioisotopes Segment by Application

Lymphoma

Thyroid

Bone Metastasis

Other

Therapeutic Radioisotopes Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Therapeutic Radioisotopes status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Therapeutic Radioisotopes market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Therapeutic Radioisotopes significant trends, drivers, influence factors in global and regions.

6. To analyze Therapeutic Radioisotopes competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Radioisotopes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Radioisotopes and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Radioisotopes.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Therapeutic Radioisotopes market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Therapeutic Radioisotopes industry.

Chapter 3: Detailed analysis of Therapeutic Radioisotopes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Therapeutic Radioisotopes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Therapeutic Radioisotopes in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Therapeutic Radioisotopes Industry Trends Table 2. Therapeutic Radioisotopes Industry Drivers Table 3. Therapeutic Radioisotopes Industry Opportunities and Challenges Table 4. Therapeutic Radioisotopes Industry Restraints Table 5. Global Therapeutic Radioisotopes Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Therapeutic Radioisotopes Revenue Share by Company (2021-2026) Table 7. Global Therapeutic Radioisotopes Sales Volume by Company (k units) & (2021-2026) Table 8. Global Therapeutic Radioisotopes Sales Volume Share by Company (2021-2026) Table 9. Global Therapeutic Radioisotopes Average Price (US$/unit) of Company (2021-2026) Table 10. Global Therapeutic Radioisotopes Company Ranking, (2024-2026) & (USD Million) Table 11. Global Therapeutic Radioisotopes Key Company Manufacturing Base & Headquarters Table 12. Global Therapeutic Radioisotopes Company, Product Type & Application Table 13. Global Therapeutic Radioisotopes Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Therapeutic Radioisotopes by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Lutetium-177 Table 18. Significant Companies of Radium-223 Table 19. Significant Companies of Iodine-131 Table 20. Significant Companies of Other Table 21. Global Therapeutic Radioisotopes Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Therapeutic Radioisotopes Sales Volume by Type (2021-2026) & (k units) Table 23. Global Therapeutic Radioisotopes Sales Volume by Type (2027-2032) & (k units) Table 24. Global Therapeutic Radioisotopes Sales Volume Share by Type (2021-2026) Table 25. Global Therapeutic Radioisotopes Sales Volume Share by Type (2027-2032) Table 26. Global Therapeutic Radioisotopes Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Therapeutic Radioisotopes Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Therapeutic Radioisotopes Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Therapeutic Radioisotopes Sales Value Share by Type (2021-2026) Table 30. Global Therapeutic Radioisotopes Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Lymphoma Table 32. Significant Companies of Thyroid Table 33. Significant Companies of Bone Metastasis Table 34. Significant Companies of Other Table 35. Global Therapeutic Radioisotopes Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Therapeutic Radioisotopes Sales Volume by Application (2021-2026) & (k units) Table 37. Global Therapeutic Radioisotopes Sales Volume by Application (2027-2032) & (k units) Table 38. Global Therapeutic Radioisotopes Sales Volume Share by Application (2021-2026) Table 39. Global Therapeutic Radioisotopes Sales Volume Share by Application (2027-2032) Table 40. Global Therapeutic Radioisotopes Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Therapeutic Radioisotopes Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Therapeutic Radioisotopes Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Therapeutic Radioisotopes Sales Value Share by Application (2021-2026) Table 44. Global Therapeutic Radioisotopes Sales Value Share by Application (2027-2032) Table 45. Global Therapeutic Radioisotopes Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Therapeutic Radioisotopes Sales by Region (2021-2026) & (k units) Table 47. Global Therapeutic Radioisotopes Sales Market Share by Region (2021-2026) Table 48. Global Therapeutic Radioisotopes Sales by Region (2027-2032) & (k units) Table 49. Global Therapeutic Radioisotopes Sales Market Share by Region (2027-2032) Table 50. Global Therapeutic Radioisotopes Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Therapeutic Radioisotopes Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Therapeutic Radioisotopes Sales Value Share by Region (2021-2026) Table 53. Global Therapeutic Radioisotopes Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Therapeutic Radioisotopes Sales Value Share by Region (2027-2032) Table 55. Global Therapeutic Radioisotopes Market Average Price (US$/unit) by Region (2021-2026) Table 56. Global Therapeutic Radioisotopes Market Average Price (US$/unit) by Region (2027-2032) Table 57. Global Therapeutic Radioisotopes Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global Therapeutic Radioisotopes Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Therapeutic Radioisotopes Sales by Country (2021-2026) & (k units) Table 60. Global Therapeutic Radioisotopes Sales Market Share by Country (2021-2026) Table 61. Global Therapeutic Radioisotopes Sales by Country (2027-2032) & (k units) Table 62. Global Therapeutic Radioisotopes Sales Market Share by Country (2027-2032) Table 63. Global Therapeutic Radioisotopes Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Therapeutic Radioisotopes Sales Value Market Share by Country (2021-2026) Table 65. Global Therapeutic Radioisotopes Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Therapeutic Radioisotopes Sales Value Market Share by Country (2027-2032) Table 67. Novartis Company Information Table 68. Novartis Business Overview Table 69. Novartis Therapeutic Radioisotopes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Novartis Therapeutic Radioisotopes Product Portfolio Table 71. Novartis Recent Development Table 72. Bayer Company Information Table 73. Bayer Business Overview Table 74. Bayer Therapeutic Radioisotopes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Bayer Therapeutic Radioisotopes Product Portfolio Table 76. Bayer Recent Development Table 77. Q BioMed Company Information Table 78. Q BioMed Business Overview Table 79. Q BioMed Therapeutic Radioisotopes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Q BioMed Therapeutic Radioisotopes Product Portfolio Table 81. Q BioMed Recent Development Table 82. Mundipharma Company Information Table 83. Mundipharma Business Overview Table 84. Mundipharma Therapeutic Radioisotopes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Mundipharma Therapeutic Radioisotopes Product Portfolio Table 86. Mundipharma Recent Development Table 87. Lantheus Company Information Table 88. Lantheus Business Overview Table 89. Lantheus Therapeutic Radioisotopes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Lantheus Therapeutic Radioisotopes Product Portfolio Table 91. Lantheus Recent Development Table 92. Jubilant Radiopharma Company Information Table 93. Jubilant Radiopharma Business Overview Table 94. Jubilant Radiopharma Therapeutic Radioisotopes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Jubilant Radiopharma Therapeutic Radioisotopes Product Portfolio Table 96. Jubilant Radiopharma Recent Development Table 97. International Isotopes Company Information Table 98. International Isotopes Business Overview Table 99. International Isotopes Therapeutic Radioisotopes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. International Isotopes Therapeutic Radioisotopes Product Portfolio Table 101. International Isotopes Recent Development Table 102. Dongcheng Company Information Table 103. Dongcheng Business Overview Table 104. Dongcheng Therapeutic Radioisotopes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Dongcheng Therapeutic Radioisotopes Product Portfolio Table 106. Dongcheng Recent Development Table 107. Curium Pharmaceuticals Company Information Table 108. Curium Pharmaceuticals Business Overview Table 109. Curium Pharmaceuticals Therapeutic Radioisotopes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Curium Pharmaceuticals Therapeutic Radioisotopes Product Portfolio Table 111. Curium Pharmaceuticals Recent Development Table 112. China Isotope & Radiation Company Information Table 113. China Isotope & Radiation Business Overview Table 114. China Isotope & Radiation Therapeutic Radioisotopes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. China Isotope & Radiation Therapeutic Radioisotopes Product Portfolio Table 116. China Isotope & Radiation Recent Development Table 117. Aurobindo Pharma Company Information Table 118. Aurobindo Pharma Business Overview Table 119. Aurobindo Pharma Therapeutic Radioisotopes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Aurobindo Pharma Therapeutic Radioisotopes Product Portfolio Table 121. Aurobindo Pharma Recent Development Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Therapeutic Radioisotopes Distributors List Table 125. Therapeutic Radioisotopes Customers List Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Therapeutic Radioisotopes Product Image Figure 2. Global Therapeutic Radioisotopes Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Therapeutic Radioisotopes Sales Value (2021-2032) & (US$ Million) Figure 4. Global Therapeutic Radioisotopes Sales (2021-2032) & (k units) Figure 5. Global Therapeutic Radioisotopes Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Therapeutic Radioisotopes Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Lutetium-177 Image Figure 10. Radium-223 Image Figure 11. Iodine-131 Image Figure 12. Other Image Figure 13. Global Therapeutic Radioisotopes Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Therapeutic Radioisotopes Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Therapeutic Radioisotopes Sales Volume Share by Type (2021-2032) Figure 16. Global Therapeutic Radioisotopes Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Therapeutic Radioisotopes Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Therapeutic Radioisotopes Sales Value Share by Type (2021-2032) Figure 19. Lymphoma Image Figure 20. Thyroid Image Figure 21. Bone Metastasis Image Figure 22. Other Image Figure 23. Global Therapeutic Radioisotopes Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Therapeutic Radioisotopes Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Therapeutic Radioisotopes Sales Volume Share by Application (2021-2032) Figure 26. Global Therapeutic Radioisotopes Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Therapeutic Radioisotopes Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Therapeutic Radioisotopes Sales Value Share by Application (2021-2032) Figure 29. Global Therapeutic Radioisotopes Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global Therapeutic Radioisotopes Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Therapeutic Radioisotopes Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Therapeutic Radioisotopes Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Therapeutic Radioisotopes Sales Value (2021-2032) & (US$ Million) Figure 34. North America Therapeutic Radioisotopes Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Therapeutic Radioisotopes Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Therapeutic Radioisotopes Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Therapeutic Radioisotopes Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Therapeutic Radioisotopes Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Therapeutic Radioisotopes Sales Value (2021-2032) & (US$ Million) Figure 40. South America Therapeutic Radioisotopes Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Therapeutic Radioisotopes Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Therapeutic Radioisotopes Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Therapeutic Radioisotopes Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Therapeutic Radioisotopes Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Lutetium-177
  • Radium-223
  • Iodine-131
  • Other
Applications
  • Lymphoma
  • Thyroid
  • Bone Metastasis
  • Other
Companies covered
  • Novartis
  • Bayer
  • Q BioMed
  • Mundipharma
  • Lantheus
  • Jubilant Radiopharma
  • International Isotopes
  • Dongcheng
  • Curium Pharmaceuticals
  • China Isotope & Radiation
  • Aurobindo Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Therapeutic Radioisotopes Sales Value (2021-2032)
  4. 1.2.2 Global Therapeutic Radioisotopes Sales Volume (2021-2032)
  5. 1.2.3 Global Therapeutic Radioisotopes Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Therapeutic Radioisotopes Market Dynamics
  1. 2.1 Therapeutic Radioisotopes Industry Trends
  2. 2.2 Therapeutic Radioisotopes Industry Drivers
  3. 2.3 Therapeutic Radioisotopes Industry Opportunities and Challenges
  4. 2.4 Therapeutic Radioisotopes Industry Restraints
3 Therapeutic Radioisotopes Market by Company
  1. 3.1 Global Therapeutic Radioisotopes Company Revenue Ranking in 2025
  2. 3.2 Global Therapeutic Radioisotopes Revenue by Company (2021-2026)
  3. 3.3 Global Therapeutic Radioisotopes Sales Volume by Company (2021-2026)
  4. 3.4 Global Therapeutic Radioisotopes Average Price by Company (2021-2026)
  5. 3.5 Global Therapeutic Radioisotopes Company Ranking (2024-2026)
  6. 3.6 Global Therapeutic Radioisotopes Company Manufacturing Base and Headquarters
  7. 3.7 Global Therapeutic Radioisotopes Company Product Type and Application
  8. 3.8 Global Therapeutic Radioisotopes Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Therapeutic Radioisotopes Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Therapeutic Radioisotopes Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Therapeutic Radioisotopes Market by Type
  1. 4.1 Therapeutic Radioisotopes Type Introduction
  2. 4.1.1 Lutetium-177
  3. 4.1.2 Radium-223
  4. 4.1.3 Iodine-131
  5. 4.1.4 Other
  6. 4.2 Global Therapeutic Radioisotopes Sales Volume by Type
  7. 4.2.1 Global Therapeutic Radioisotopes Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Therapeutic Radioisotopes Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Therapeutic Radioisotopes Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Therapeutic Radioisotopes Sales Value by Type
  11. 4.3.1 Global Therapeutic Radioisotopes Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Therapeutic Radioisotopes Sales Value by Type (2021-2032)
  13. 4.3.3 Global Therapeutic Radioisotopes Sales Value Share by Type (2021-2032)
5 Therapeutic Radioisotopes Market by Application
  1. 5.1 Therapeutic Radioisotopes Application Introduction
  2. 5.1.1 Lymphoma
  3. 5.1.2 Thyroid
  4. 5.1.3 Bone Metastasis
  5. 5.1.4 Other
  6. 5.2 Global Therapeutic Radioisotopes Sales Volume by Application
  7. 5.2.1 Global Therapeutic Radioisotopes Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Therapeutic Radioisotopes Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Therapeutic Radioisotopes Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Therapeutic Radioisotopes Sales Value by Application
  11. 5.3.1 Global Therapeutic Radioisotopes Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Therapeutic Radioisotopes Sales Value by Application (2021-2032)
  13. 5.3.3 Global Therapeutic Radioisotopes Sales Value Share by Application (2021-2032)
6 Therapeutic Radioisotopes Regional Sales and Value Analysis
  1. 6.1 Global Therapeutic Radioisotopes Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Therapeutic Radioisotopes Sales by Region (2021-2032)
  3. 6.2.1 Global Therapeutic Radioisotopes Sales by Region: 2021-2026
  4. 6.2.2 Global Therapeutic Radioisotopes Sales by Region (2027-2032)
  5. 6.3 Global Therapeutic Radioisotopes Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Therapeutic Radioisotopes Sales Value by Region (2021-2032)
  7. 6.4.1 Global Therapeutic Radioisotopes Sales Value by Region: 2021-2026
  8. 6.4.2 Global Therapeutic Radioisotopes Sales Value by Region (2027-2032)
  9. 6.5 Global Therapeutic Radioisotopes Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Therapeutic Radioisotopes Sales Value (2021-2032)
  12. 6.6.2 North America Therapeutic Radioisotopes Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Therapeutic Radioisotopes Sales Value (2021-2032)
  15. 6.7.2 Europe Therapeutic Radioisotopes Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Therapeutic Radioisotopes Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Therapeutic Radioisotopes Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Therapeutic Radioisotopes Sales Value (2021-2032)
  21. 6.9.2 South America Therapeutic Radioisotopes Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Therapeutic Radioisotopes Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Therapeutic Radioisotopes Sales Value Share by Country, 2025 VS 2032
7 Therapeutic Radioisotopes Country-level Sales and Value Analysis
  1. 7.1 Global Therapeutic Radioisotopes Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Therapeutic Radioisotopes Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Therapeutic Radioisotopes Sales by Country (2021-2032)
  4. 7.3.1 Global Therapeutic Radioisotopes Sales by Country (2021-2026)
  5. 7.3.2 Global Therapeutic Radioisotopes Sales by Country (2027-2032)
  6. 7.4 Global Therapeutic Radioisotopes Sales Value by Country (2021-2032)
  7. 7.4.1 Global Therapeutic Radioisotopes Sales Value by Country (2021-2026)
  8. 7.4.2 Global Therapeutic Radioisotopes Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Therapeutic Radioisotopes Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Therapeutic Radioisotopes Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Therapeutic Radioisotopes Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis Therapeutic Radioisotopes Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novartis Therapeutic Radioisotopes Product Portfolio
  6. 8.1.5 Novartis Recent Developments
  7. 8.2 Bayer
  8. 8.2.1 Bayer Company Information
  9. 8.2.2 Bayer Business Overview
  10. 8.2.3 Bayer Therapeutic Radioisotopes Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bayer Therapeutic Radioisotopes Product Portfolio
  12. 8.2.5 Bayer Recent Developments
  13. 8.3 Q BioMed
  14. 8.3.1 Q BioMed Company Information
  15. 8.3.2 Q BioMed Business Overview
  16. 8.3.3 Q BioMed Therapeutic Radioisotopes Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Q BioMed Therapeutic Radioisotopes Product Portfolio
  18. 8.3.5 Q BioMed Recent Developments
  19. 8.4 Mundipharma
  20. 8.4.1 Mundipharma Company Information
  21. 8.4.2 Mundipharma Business Overview
  22. 8.4.3 Mundipharma Therapeutic Radioisotopes Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Mundipharma Therapeutic Radioisotopes Product Portfolio
  24. 8.4.5 Mundipharma Recent Developments
  25. 8.5 Lantheus
  26. 8.5.1 Lantheus Company Information
  27. 8.5.2 Lantheus Business Overview
  28. 8.5.3 Lantheus Therapeutic Radioisotopes Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Lantheus Therapeutic Radioisotopes Product Portfolio
  30. 8.5.5 Lantheus Recent Developments
  31. 8.6 Jubilant Radiopharma
  32. 8.6.1 Jubilant Radiopharma Company Information
  33. 8.6.2 Jubilant Radiopharma Business Overview
  34. 8.6.3 Jubilant Radiopharma Therapeutic Radioisotopes Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jubilant Radiopharma Therapeutic Radioisotopes Product Portfolio
  36. 8.6.5 Jubilant Radiopharma Recent Developments
  37. 8.7 International Isotopes
  38. 8.7.1 International Isotopes Company Information
  39. 8.7.2 International Isotopes Business Overview
  40. 8.7.3 International Isotopes Therapeutic Radioisotopes Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 International Isotopes Therapeutic Radioisotopes Product Portfolio
  42. 8.7.5 International Isotopes Recent Developments
  43. 8.8 Dongcheng
  44. 8.8.1 Dongcheng Company Information
  45. 8.8.2 Dongcheng Business Overview
  46. 8.8.3 Dongcheng Therapeutic Radioisotopes Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Dongcheng Therapeutic Radioisotopes Product Portfolio
  48. 8.8.5 Dongcheng Recent Developments
  49. 8.9 Curium Pharmaceuticals
  50. 8.9.1 Curium Pharmaceuticals Company Information
  51. 8.9.2 Curium Pharmaceuticals Business Overview
  52. 8.9.3 Curium Pharmaceuticals Therapeutic Radioisotopes Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Curium Pharmaceuticals Therapeutic Radioisotopes Product Portfolio
  54. 8.9.5 Curium Pharmaceuticals Recent Developments
  55. 8.10 China Isotope & Radiation
  56. 8.10.1 China Isotope & Radiation Company Information
  57. 8.10.2 China Isotope & Radiation Business Overview
  58. 8.10.3 China Isotope & Radiation Therapeutic Radioisotopes Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 China Isotope & Radiation Therapeutic Radioisotopes Product Portfolio
  60. 8.10.5 China Isotope & Radiation Recent Developments
  61. 8.11 Aurobindo Pharma
  62. 8.11.1 Aurobindo Pharma Company Information
  63. 8.11.2 Aurobindo Pharma Business Overview
  64. 8.11.3 Aurobindo Pharma Therapeutic Radioisotopes Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Aurobindo Pharma Therapeutic Radioisotopes Product Portfolio
  66. 8.11.5 Aurobindo Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Therapeutic Radioisotopes Value Chain Analysis
  2. 9.1.1 Therapeutic Radioisotopes Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Therapeutic Radioisotopes Sales Mode & Process
  6. 9.2 Therapeutic Radioisotopes Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Therapeutic Radioisotopes Distributors
  9. 9.2.3 Therapeutic Radioisotopes Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst